Literature DB >> 12446285

Role of the area postrema in angiotensin II modulation of baroreflex control of heart rate in conscious mice.

Baojian Xue1, Hope Gole, Jaya Pamidimukkala, Meredith Hay.   

Abstract

This study reports the effects of angiotensin II (ANG II), arginine vasopression (AVP), phenylephrine (PE), and sodium nitroprusside (SNP) on baroreflex control of heart rate in the presence and absence of the area postrema (AP) in conscious mice. In intact, sham-lesioned mice, baroreflex-induced decreases in heart rate due to increases in arterial pressure with intravenous infusions of ANG II were significantly less than those observed with similar increases in arterial pressure with PE (slope: -3.0 +/- 0.9 vs. -8.1 +/- 1.5 beats x min(-1) x mmHg(-1)). Baroreflex-induced decreases in heart rate due to increases in arterial pressure with intravenous infusions of AVP were the same as those observed with PE in sham animals (slope: -5.8 +/- 0.7 vs. -8.1 +/- 1.5 beats x min(-1) x mmHg(-1)). After the AP was lesioned, the slope of baroreflex inhibition of heart rate was the same whether pressure was increased with ANG II, AVP, or PE. The slope of the baroreflex-induced increases in heart rate due to decreases in arterial blood pressure with SNP were the same in sham- and AP-lesioned animals. These results indicate that, similar to other species, in mice the ability of ANG II to acutely reset baroreflex control of heart rate is dependent on an intact AP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446285     DOI: 10.1152/ajpheart.00793.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Oestrogen affects the cardiovascular and central responses to isoproterenol of female rats.

Authors:  Eric G Krause; Kathleen S Curtis; Jason P Markle; Robert J Contreras
Journal:  J Physiol       Date:  2007-04-12       Impact factor: 5.182

2.  Autonomic dysregulation in ob/ob mice is improved by inhibition of angiotensin-converting enzyme.

Authors:  Aline M Hilzendeger; Andrey C da Costa Goncalves; Ralph Plehm; André Diedrich; Volkmar Gross; Joao B Pesquero; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2009-12-12       Impact factor: 4.599

Review 3.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

4.  Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension.

Authors:  Heddwen L Brooks; Meredith Hay; Dennis P Pollow; Jennifer Uhrlaub; Melissa Romero-Aleshire; Kathryn Sandberg; Janko Nikolich-Zugich
Journal:  Hypertension       Date:  2014-06-02       Impact factor: 10.190

5.  Evaluation of the hematoma consequences, neurobehavioral profiles, and histopathology in a rat model of pontine hemorrhage.

Authors:  Tim Lekic; William Rolland; Anatol Manaenko; Paul R Krafft; Joel E Kamper; Hidenori Suzuki; Richard E Hartman; Jiping Tang; John H Zhang
Journal:  J Neurosurg       Date:  2012-11-30       Impact factor: 5.115

Review 6.  Posterior circulation stroke: animal models and mechanism of disease.

Authors:  Tim Lekic; Chizobam Ani
Journal:  J Biomed Biotechnol       Date:  2012-05-14

7.  Parental Renovascular Hypertension-Induced Autonomic Dysfunction in Male Offspring Is Improved by Prenatal or Postnatal Treatment With Hydrogen Sulfide.

Authors:  Qi Guo; Xiaohong Feng; Hongmei Xue; Sheng Jin; Xu Teng; Xiaocui Duan; Lin Xiao; Yuming Wu
Journal:  Front Physiol       Date:  2019-09-19       Impact factor: 4.566

Review 8.  Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension.

Authors:  Julia Shanks; Rohit Ramchandra
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

9.  Androgen receptors in areas of the spinal cord and brainstem: A study in adult male cats.

Authors:  Rosa L Coolen; Jacqueline C Cambier; Panagiota I Spantidea; Els van Asselt; Bertil F M Blok
Journal:  J Anat       Date:  2021-02-22       Impact factor: 2.610

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.